本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Madrigal Pharmaceuticals, Inc.

334.13
-14.6000-4.19%
盘后334.130.00000.00%17:38 EDT
成交量:32.60万
成交额:1.10亿
市值:74.19亿
市盈率:-18.60
高:351.20
开:350.00
低:331.24
收:348.73
数据加载中...
2024/03/25

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/20

重要事件披露

Form 8-K - Current report
2024/03/15

重要事件披露

Form 8-K - Current report
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

SEC问询函

Form CORRESP - Correspondence
2024/01/09

重要事件披露

Form 8-K - Current report
2023/12/14

SEC问询函

Form CORRESP - Correspondence
2023/12/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/08

SEC问询函

Form CORRESP - Correspondence
2023/11/22

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/06

重要事件披露

Form 8-K - Current report
2023/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]